Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 74.15
+0.45 (0.61%)
Jun 18, 2026, 11:02 AM CET
Apotea AB Market Cap
Apotea AB has a market cap or net worth of 7.67 billion as of June 17, 2026. Its market cap has decreased by -29.49% in one year.
Market Cap
7.67B
Enterprise Value
7.88B
Revenue
7.39B
Ranking
n/a
PE Ratio
32.47
Stock Price
74.15
Market Cap Chart
Since December 6, 2024, Apotea AB's market cap has decreased from 8.63B to 7.67B, a decrease of -11.13%. That is a compound annual growth rate of -7.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 7.67B | -20.08% |
| Dec 30, 2025 | 9.60B | 9.72% |
| Dec 30, 2024 | 8.75B | 1.35% |
| Dec 6, 2024 | 8.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 150.44B |
| Sectra AB | 56.30B |
| Getinge AB | 53.52B |
| Camurus AB | 32.74B |
| Ambea AB | 11.07B |
| Xvivo Perfusion AB | 8.52B |
| Synsam AB | 8.06B |
| Dynavox Group AB | 7.48B |